Notes

Novel and Efficient Synthesis of 6-Bromofuro[2,3-d]pyrimidine Bicyclic Nucleosides

  • Fan Xuesen ,
  • Li Peiyuan ,
  • Li Kun ,
  • Zhang Xinying ,
  • Zhao Wan
Expand
  • a School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang 453007;
    b Department of Chemistry, Zhoukou Normal University, Zhoukou 466000

Received date: 2013-11-13

  Revised date: 2013-12-28

  Online published: 2014-01-22

Supported by

Project supported by the National Natural Science Foundation of China (Nos. 21172057, 21272058), the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (No. IRT 1061), and the Research Fund for the Doctoral Program of Higher Education (RFDP) (No. 20114104110005).

Abstract

6-Bromofuro[2,3-d]pyrimidine bicyclic nucleosides are the key intermediates for the preparation of novel furo[2,3-d]pyrimidine bicyclic nucleoside derivatives with remarkable antiviral potency. The literature protocol for their synthesis involves a multi-step procedure and palladium catalyst. In this paper, an economical and practical method for their preparation is developed via condensation of the easily obtainable 5-formyl pyrimidine nucleosides with carbon tetrabromide and subsequent cyclization promoted by copper iodide.

Cite this article

Fan Xuesen , Li Peiyuan , Li Kun , Zhang Xinying , Zhao Wan . Novel and Efficient Synthesis of 6-Bromofuro[2,3-d]pyrimidine Bicyclic Nucleosides[J]. Chinese Journal of Organic Chemistry, 2014 , 34(5) : 999 -1005 . DOI: 10.6023/cjoc201311020

References

[1] (a) De Clercq, E. Rev. Med. Virol. 2009, 19, 287.

(b) De Clercq, E. J. Med. Chem. 2010, 53, 1438.

[2] Zhang, X.-Y.; Wang, Y.-Y.; Feng, D.; Fan, X.-S. Chin. J. Org. Chem. 2010, 30, 797 (in Chinese).

(张新迎, 王洋洋, 冯东, 范学森, 有机化学, 2010, 30, 797.)

[3] Topalis, D.; Pradère, U.; Roy, V.; Caillat, C.; Azzouzi, A.; Broggi, J.; Snoeck, R.; Andrei, G.; Lin, J.; Eriksson, S.; Alexandre, J. A. C.; El-Amri, C.; Deville-Bonne, D.; Meyer, P.; Balzarini, J.; Agrofoglio, L. A. J. Med. Chem. 2011, 54, 222.

[4] Srivastav, N. C.; Mak, M.; Agrawal, B.; Tyrrell, D. L. J.; Kumar, R. Bioorg. Med. Chem. Lett. 2010, 20, 6790.

[5] McGuigan, C.; Yarnold, C. J.; Jones, C.; Velázquez, S.; Barucki, H.; Brancale, A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. J. Med. Chem. 1999, 42, 4479.

[6] Balzarini, J.; McGuigan, C. J. Antimicrob. Chemother. 2002, 50, 5.

[7] Janeba, Z.; Balzarini, J.; Andrei, G.; Snoeck, R.; De Clercq, E.; Robins, M. J. J. Med. Chem. 2005, 48, 4690.

[8] Januszczyk, P.; Fogt, J.; Boryski, J.; Izawa, K.; Onishi, T.; Neyts, J.; De Clercq, E. Nucleosides Nucleotides Nucleic Acids 2009, 28, 713.

[9] Kifli, N.; De Clercq, E.; Balzarini, J.; Simons, C. Bioorg. Med. Chem. 2004, 12, 4245.

[10] Robins, M. J.; Barr, P. J. J. Org. Chem. 1983, 48, 1854.

[11] Jin, Y.-Y.; Xiao, Q.; Ju, Y. Chin. J. Org. Chem. 2009, 29, 44 (in Chinese).

(靳玄烨, 肖强, 巨勇, 有机化学, 2009, 29, 44.)

[12] McGuigan, C.; Barucki, H.; Blewett, S.; Carangio, A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. J. Med. Chem. 2000, 43, 4993.

[13] De Clercq, E. Med. Res. Rev. 2009, 29, 571.

[14] Migliore, M. Antiviral Chem. Chemother. 2010, 20, 107.

[15] Robins, M. J.; Miranda, K.; Rajwanshi, V. K.; Peterson, M. A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. J. Med. Chem. 2006, 49, 391.

[16] Newman, S. G.; Aureggi, V.; Bryan, C. S.; Lautens, M. Chem. Commun. 2009, 5236.

[17] Chen, W.; Zhang, Y.-C.; Zhang, L.; Wang, M.; Wang, L. Chem. Commun. 2011, 10476.

[18] Fan, X.-S.; Wang, Y.-Y.; Qu, Y.-Y.; Xu, H.-Y.; He, Y.; Zhang, X.-Y.; Wang, J.-J. J. Org. Chem. 2011, 76, 982.

[19] Desai, N. B.; McKelvie, N.; Ramirez, F. J. Am. Chem. Soc. 1962, 84, 1745.Corey, E. J.; Fuchs, P. L. Tetrahedron Lett. 1972, 13, 3769.

Outlines

/